Free Trial

Alcon (ALC) Stock Forecast & Price Target

Alcon logo
$98.39 +2.22 (+2.31%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$98.92 +0.53 (+0.54%)
As of 05/2/2025 04:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alcon - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
4
Buy
10

Based on 14 Wall Street analysts who have issued ratings for Alcon in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 4 have given a hold rating, and 10 have given a buy rating for ALC.

Consensus Price Target

$106.22
7.96% Upside
According to the 14 analysts' twelve-month price targets for Alcon, the average price target is $106.22. The highest price target for ALC is $120.00, while the lowest price target for ALC is $85.00. The average price target represents a forecasted upside of 7.96% from the current price of $98.39.
Get the Latest News and Ratings for ALC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Alcon and its competitors.

Sign Up

ALC Analyst Ratings Over Time

TypeCurrent Forecast
5/3/24 to 5/3/25
1 Month Ago
4/3/24 to 4/3/25
3 Months Ago
2/3/24 to 2/2/25
1 Year Ago
5/4/23 to 5/3/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
11 Buy rating(s)
12 Buy rating(s)
11 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$106.22$105.60$102.38$91.22
Forecasted Upside7.96% Upside17.91% Upside12.30% Upside14.65% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

ALC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ALC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Alcon Stock vs. The Competition

TypeAlconMedical CompaniesS&P 500
Consensus Rating Score
2.71
2.81
2.54
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside7.96% Upside3,335.48% Upside17.54% Upside
News Sentiment Rating
Neutral News

See Recent ALC News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/31/2025KeyCorp
3 of 5 stars
Brett Fishbin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$108.00 ➝ $112.00+18.41%
3/28/2025Mizuho
3 of 5 stars
Anthony Petrone
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$115.00 ➝ $120.00+23.78%
3/28/2025Needham & Company LLC
2 of 5 stars
David Saxon
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$107.00 ➝ $110.00+13.47%
3/25/2025HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeHold
3/25/2025Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Kumar
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
3/25/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy
2/27/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jeff Johnson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$104.00 ➝ $108.00+15.81%
1/10/2025Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
I. Kirby
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy
11/26/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Zimmerman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
9/10/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Reynolds-Clar
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform ➝ Outperform
8/22/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$94.00 ➝ $105.00+9.88%
8/22/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$103.00 ➝ $110.00+16.25%
7/15/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Equal Weight$65.00 ➝ $85.00-7.35%
5/15/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$95.00 ➝ $100.00+12.02%
4/10/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$100.00+20.95%
3/4/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$90.00 ➝ $100.00+16.31%
2/29/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$93.00 ➝ $96.60+13.10%
11/20/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$94.00 ➝ $88.00+23.40%
8/17/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$79.80 ➝ $89.30+11.29%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:25 PM ET.


Should I Buy Alcon Stock? ALC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, April 22, 2025. Please send any questions or comments about these Alcon pros and cons to contact@marketbeat.com.

Alcon
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Alcon Inc.:

  • The current stock price is around $91.98, reflecting a positive trend in the company's market performance.
  • Alcon Inc. has shown a strong fifty-two week performance, with an increase of approximately 26.72%, indicating robust growth potential.
  • The company maintains a significant institutional ownership percentage of about 72.64%, suggesting confidence from large investors in its future prospects.
  • With a relatively low short percentage of float at 0.65%, there is less risk of a short squeeze, which can lead to price volatility.
  • Alcon Inc. has a solid average daily trading volume, which enhances liquidity and allows for easier entry and exit from positions.

Alcon
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Alcon Inc. for these reasons:

  • The company has experienced a month-to-month increase in shares shorted, which could indicate growing bearish sentiment among investors.
  • Days to cover is relatively high at 4.5, suggesting that if many investors decide to sell short, it could take longer to cover those positions, potentially leading to price pressure.
  • Despite recent performance, the overall market conditions can be unpredictable, which may affect Alcon Inc.'s stock price negatively.
  • There has been a slight decrease in the number of shares shorted compared to the previous month, which may indicate a lack of strong bullish momentum.
  • Investors should consider the competitive landscape in the healthcare sector, which can impact Alcon Inc.'s market share and profitability.

ALC Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Alcon is $106.22, with a high forecast of $120.00 and a low forecast of $85.00.

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last twelve months. There are currently 4 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ALC shares.

According to analysts, Alcon's stock has a predicted upside of 7.96% based on their 12-month stock forecasts.

Over the previous 90 days, Alcon's stock had 2 downgrades and 1 upgrade by analysts.

Alcon has been rated by research analysts at Bank of America, Hsbc Global Res, HSBC, KeyCorp, Mizuho, Needham & Company LLC, and Robert W. Baird in the past 90 days.

Analysts like Alcon less than other "medical" companies. The consensus rating score for Alcon is 2.71 while the average consensus rating score for "medical" companies is 2.81. Learn more on how ALC compares to other companies.


This page (NYSE:ALC) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners